Kohlberg & Company acquire Nelipak® Healthcare Packaging


CRANSTON, R.I., July 02, 2019 (GLOBE NEWSWIRE) -- Nelipak® Corporation, Inc. (“Nelipak”), the leading provider of custom designed rigid packaging for the medical device and pharmaceutical industries, announced today that it has been acquired by Kohlberg & Company, L.L.C. (Kohlberg), a private equity firm headquartered in Mount Kisco, NY., from Mason Wells. The business will continue to operate under the name of Nelipak® Healthcare Packaging. 

Headquartered in Cranston, Rhode Island, Nelipak is the leading global manufacturer of custom-designed rigid healthcare packaging used for Class II and Class III medical devices, and pharma drug delivery products. The company operates strategically located cleanroom facilities meeting customers’ most stringent packaging requirements. Nelipaks’ experienced in-house design, development, prototyping, manufacturing and quality teams offer medical trays and blisters, surgical procedure trays, pharmaceutical handling trays, custom built sealing machines and other value-added services. With a staff of over 800, the company operates from seven production facilities, five in the Americas – located in Cranston, RI.; Whitehall, PA; Phoenix, AZ.; Humacao, Puerto Rico, San Jose, Costa Rica; two in Europe - located in Venray, the Netherlands and Galway, Ireland.

“We have accomplished a lot at Nelipak during the past six years, and we are very grateful for the support given to us by Mason Wells. Our future is very bright with Kohlberg,” said Mike Kelly, President and CEO of Nelipak. “Kohlberg is committed to investing in Nelipak to make us an even stronger organization with additional capabilities to offer our customers around the world. With our global locations, world class design team, modern cleanroom manufacturing, strong sales organization and experienced management team, Nelipak is well positioned to take advantage of growth opportunities in the market.”

“Nelipak has successfully transformed itself into a leading global player in healthcare packaging and an ideal platform for further industry consolidation,” commented Seth H. Hollander, Partner of Kohlberg. “Our plans include leveraging Mike and his team, and their customer relationships, with sizeable, global acquisitions.” Roger Prevot, Operating Partner of Kohlberg, added, “A business with Nelipak’s global market position represents a unique investment opportunity. We look forward to supporting Mike and his team as they continue to execute their plan for organic and M&A-driven growth, while continuing to provide their customers with best-in-class service.”

About Nelipak® Healthcare Packaging

With facilities in Cranston, RI; Whitehall, PA; Phoenix, AZ; Venray, the Netherlands; Galway, Ireland; Humacao, Puerto Rico; and San Jose, Costa Rica, Nelipak® Healthcare Packaging designs, develops and manufactures custom thermoformed packaging products that provide superior protection for medical devices and pharmaceuticals. The company offers medical trays and blisters, surgical procedure trays, pharmaceutical handling trays, custom built sealing machines and other value-added services. Nelipak® Healthcare Packaging customers consist of some of the largest and most reputable medical device and pharmaceutical companies in the world. With over 800 employees worldwide, Nelipak® is focused on delivering superior quality and customer experience through world class manufacturing at each of its locations.

Nelipak® Healthcare Packaging is a trade name of Nelipak Corporation

About Kohlberg & Company, LLC 

Kohlberg & Company, LLC (“Kohlberg”) is a leading private equity firm headquartered in Mount Kisco, New York. Since its inception in 1987, Kohlberg has organized eight private equity funds, through which it has raised over $7.5 billion of committed equity capital. Over its 32-year history, Kohlberg has completed 76 platform investments and nearly 200 add-on acquisitions, with an aggregate transaction value in excess of $15 billion. For more information, please visit

About GlobeNewswire

One Liberty Plaza - 165 Broadway
NY 10006 New York

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire

Subscribe to all the latest releases from GlobeNewswire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire

Arion Bank hf. concludes Tier 2 bond offering denominated in Icelandic krona12.12.2019 18:59:00 CETPress release

Today Arion Bank hf. concluded the sale of two Tier 2 bonds, ARION T2 30 and ARION T2I, denominated in ISK. The total demand in the issue amounted to ISK 1,980 million and 10 bids were received. ARION T2 30, the fixed rate issue, attracted 1 bid of ISK 100 million at a yield of 6.90%. No bids were accepted. ARION T2I 30, the new inflation-linked issue, attracted 9 bids of ISK 1,880 million at a yield of 3.80-4.20%. Bids for a nominal amount of ISK 1,780 million at a yield of 3.95% were accepted. The size of the series following the issuance will be ISK 5,200 m. The bonds constitute Tier 2 capital under Icelandic act on financial undertakings no. 161/2002. Both series pay interest semi-annually, mature in January 2030 and are callable on and after January 2025. The bonds are expected to be listed on Nasdaq Iceland. For further information please contact Investor Relations, at tel: +354 444 6760

ING Group 2019 SREP process completed12.12.2019 18:30:00 CETPress release

ING Group 2019 SREP process completed ING Group has been notified of the European Central Bank (ECB) decision on the 2019 Supervisory Review and Evaluation Process (SREP), based on which it has taken a decision on ING’s prudential requirements, including capital requirements for 2020. The common equity Tier 1 requirement for ING Group will increase during the year from the current 11.83% to 11.96% as of 1 August 2020. The higher requirement is caused by the increase of the mandatory countercyclical buffer in 2020. As of 31 October 2019, ING fully-loaded common equity Tier 1 ratio was 14.6%, well in excess of the regulatory requirements. Further information on our capital requirements and resolution plans can be found in the updated ING Group Credit Update presentation on the Fixed Income Section of our website. Note for editors For further information on ING, please visit Frequent news updates can be found in the Newsroom or via the @ING_news Twitter feed. Photos of ING op

EdtechX Holdings (NASDAQ:EDTX) Announces Merger Agreement With Meten Education (China)12.12.2019 18:29:00 CETPress release

EdtechX Holdings (Nasdaq: EDTX) announces education technology transaction with Meten Education and its digital platform Likeshuo (China) London, Dec. 12, 2019 (GLOBE NEWSWIRE) -- EdtechX Holdings (“EdtechX”) (Nasdaq: EDTX), a special purpose acquisition company (“SPAC”) seeking to acquire a target in the education services and education technology industry, announced today that it has entered into a definitive merger agreement with Meten Education (China) (“Meten”). Meten and its digital platform Likeshuo are a market leader in English Learning Training (“ELT”) in China. The combined entity (“New Holdco”) will operate as Meten EdtechX and focus on providing industry leading English and future skills training for a growing market of Chinese students and young professionals. Meten EdtechX intends to pursue expansion plans including market consolidation in China and the roll out of Meten’s existing omnichannel distribution platform, combining digital delivery and strategic retail presenc

Bergman & Beving AB: Återköp av egna aktier12.12.2019 17:33:00 CETPressemelding

Pressrelease Bergman & Beving AB återköp av egna aktier I enlighet med bemyndigandet från årsstämman den 26 augusti 2019 har Bergman & Beving AB idag återköpt 40 000 B-aktier till en genomsnittskurs om 76,60 kr. Bergman & Beving AB:s totala innehav av egna aktier efter återköpet uppgår till 729 677 B-aktier. Det totala antalet aktier i Bergman & Beving AB, inklusive de av bolaget ägda aktierna, uppgår till 27 436 416 st, och antalet utestående aktier uppgår till 26 706 739. Stockholm den 12 december 2019 Bergman & Beving AB (publ) För ytterligare information kontakta: Peter Schön, CFO, telefon 070-339 89 99 Informationen lämnades, genom ovanstående kontaktpersons försorg, för offentliggörande den 12 december 2019 kl. 17:30 CET. Bergman & Beving äger och förädlar bolag som utvecklar och marknadsför starka varumärken till professionella användare inom industri och bygg - främst i Norden, Baltikum och Polen. Bergman & Beving ska vara den plats där framgångsrika produktbolag kan ta nästa s

Bergman & Beving AB: Repurchase of own shares12.12.2019 17:33:00 CETPress release

Press release Bergman & Beving AB repurchase of own shares In accordance with the authorisation issued by the Annual General Meeting of Shareholders held on 26 August 2019, Bergman & Beving AB has today repurchased 40,000 B shares at an average price of SEK 76,60 per share. After the repurchase, the total number of shares held in treasury amounts to 729,677 class B shares. The total number of shares in Bergman & Beving AB amounts to 27,436,416 and the number of shares outstanding is 26,706,739. Stockholm, 12 December 2019 Bergman & Beving AB (publ) For further information, please contact: Peter Schön, CFO, Tel: +46 70 339 89 99 The information was submitted for publication, through the agency of the contact person set out above, at 17:30 CET on 12 December 2019. Bergman & Beving owns and refines companies that develop and market strong brands for professional users in industry and construction, mainly in the Nordic region, the Baltic States and Poland. Bergman & Beving aims to enable s